Tokyo, Japan

Koumei Ohta

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Taisho Pharmaceutical Co., Ltd.. Active years: 1996-2014.

USPTO Granted Patents = 3 

% Patents Active = 66.7

 

Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Tokyo, JP (1996 - 1999)
  • Toshima-ku, JP (2014)

Company Filing History:


Years Active: 1996-2014

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Koumei Ohta: Innovator in Pharmaceutical Chemistry

Introduction

Koumei Ohta is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative processes and compounds. With a total of 3 patents, Ohta continues to push the boundaries of scientific research and development.

Latest Patents

Ohta's latest patents include a groundbreaking process for producing 3-alkoxy-2-amino-6-fluorobicyclo [3.1.0] hexane-2,6-dicarboxylic acid derivative. This process involves converting a compound represented by a specific formula to the desired compound or its salt. Additionally, he has developed optically active substituted phenylalkylamine derivatives, which further showcase his expertise in creating novel pharmaceutical compounds.

Career Highlights

Koumei Ohta is currently associated with Taisho Pharmaceutical Co., Ltd., where he applies his knowledge and skills to advance pharmaceutical innovations. His work has not only contributed to the company's success but has also had a lasting impact on the industry.

Collaborations

Ohta collaborates with esteemed colleagues such as Atsuro Nakazato and Yutaka Kawashima. Their combined efforts in research and development have led to significant advancements in their respective fields.

Conclusion

Koumei Ohta is a distinguished inventor whose work in pharmaceutical chemistry continues to influence the industry. His innovative patents and collaborations highlight his commitment to advancing science and improving healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…